581 related articles for article (PubMed ID: 15099889)
21. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
[TBL] [Abstract][Full Text] [Related]
22. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
Samuelsson E; Hägg S
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
[TBL] [Abstract][Full Text] [Related]
23. Thromboembolism during hormone therapy in Japanese women.
Adachi T; Sakamoto S
Semin Thromb Hemost; 2005 Jun; 31(3):272-80. PubMed ID: 16052396
[TBL] [Abstract][Full Text] [Related]
24. Hormones and pregnancy: thromboembolic risks for women.
Kujovich JL
Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
[TBL] [Abstract][Full Text] [Related]
25. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism associated with pregnancy and hormonal therapy.
Jacobsen AF; Sandset PM
Best Pract Res Clin Haematol; 2012 Sep; 25(3):319-32. PubMed ID: 22959548
[TBL] [Abstract][Full Text] [Related]
27. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].
Samama MM; Rached RA; Conard J; Horellou MH; Elalamy I
Bull Acad Natl Med; 2004; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665
[TBL] [Abstract][Full Text] [Related]
28. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
Gomes MP; Deitcher SR
Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
[TBL] [Abstract][Full Text] [Related]
29. [Incidence and risk factors for venous thromboembolism].
Oger E; Mottier D
Rev Prat; 2007 Apr; 57(7):711-3, 716, 719-20. PubMed ID: 17626316
[TBL] [Abstract][Full Text] [Related]
30. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study.
Larsen TB; Sørensen HT; Gislum M; Johnsen SP
Thromb Res; 2007; 120(4):505-9. PubMed ID: 17257657
[TBL] [Abstract][Full Text] [Related]
31. [Prophylaxis of recurrence during transient risk in patients with previous venous thromboembolism].
Schmidt B; Schellong S
Med Klin (Munich); 2003 Aug; 98(8):447-52. PubMed ID: 12928810
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for venous thromboembolism.
Anderson FA; Spencer FA
Circulation; 2003 Jun; 107(23 Suppl 1):I9-16. PubMed ID: 12814980
[TBL] [Abstract][Full Text] [Related]
33. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
Mills A; Wilkinson C; Fotherby K
Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
[TBL] [Abstract][Full Text] [Related]
34. Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium.
Nelson SM; Greer IA
Obstet Gynecol Clin North Am; 2006 Sep; 33(3):413-27. PubMed ID: 16962918
[TBL] [Abstract][Full Text] [Related]
35. Venous thromboembolism after spinal cord injury: incidence, time course, and associated risk factors in 16,240 adults and children.
Jones T; Ugalde V; Franks P; Zhou H; White RH
Arch Phys Med Rehabil; 2005 Dec; 86(12):2240-7. PubMed ID: 16344018
[TBL] [Abstract][Full Text] [Related]
36. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
[TBL] [Abstract][Full Text] [Related]
37. PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM (VTE) IN OBSTETRICS.
Kent N; Leduc L; Crane J; Farine D; Hodges S; Reid GJ; Van Aerde J
J SOGC; 2000 Sep; 22(9):736-749. PubMed ID: 12457202
[TBL] [Abstract][Full Text] [Related]
38. Oral contraceptives, hormone therapy and cardiovascular risk.
Shapiro S
Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
[TBL] [Abstract][Full Text] [Related]
39. Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia.
De Stefano V; Rossi E; Za T; Leone G
Semin Thromb Hemost; 2006 Nov; 32(8):767-80. PubMed ID: 17171589
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
